as 09-17-2025 3:20pm EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Founded: | 1999 | Country: | United States |
Employees: | N/A | City: | BRENTWOOD |
Market Cap: | 438.7M | IPO Year: | N/A |
Target Price: | $11.70 | AVG Volume (30 days): | 578.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.35 | EPS Growth: | N/A |
52 Week Low/High: | $4.58 - $10.46 | Next Earning Date: | 11-06-2025 |
Revenue: | $237,879,000 | Revenue Growth: | 24.93% |
Revenue Growth (this year): | -23.87% | Revenue Growth (next year): | 9.08% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Hariri Robert J | CYRX | Director | Sep 11 '25 | Sell | $9.71 | 25,000 | $242,737.50 | 51,275 | |
STEFANOVICH ROBERT | CYRX | Chief Financial Officer | Aug 19 '25 | Sell | $8.67 | 9,300 | $80,617.98 | 207,213 | |
Mandalam Ramkumar | CYRX | Director | Jun 24 '25 | Sell | $7.02 | 13,321 | $93,446.82 | 73,056 | |
SHELTON JERRELL | CYRX | President, CEO | Jun 24 '25 | Sell | $7.06 | 16,344 | $115,365.76 | 912,419 |
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
Zacks
3 months ago
MT Newswires
3 months ago
MT Newswires
3 months ago
PR Newswire
3 months ago
Zacks
4 months ago
Zacks
4 months ago
Simply Wall St.
4 months ago
GuruFocus.com
4 months ago
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.